Current options of prediction of preterm labour

Česká verzia

Authors: J. Dudášová; P. Šimják ; M. Koucký; A. Pařízek
Authors place of work: Gynekologicko-porodnická klinika 1. LF UK a VFN, Praha, přednosta prof. MUDr. A. Martan, DrSc.
Published in the journal: Ceska Gynekol 2019; 84(5): 355-360
Category:

Summary

Objective: A summary of current possibilities to adequately determine spontaneous preterm labour.

Design: Review.

Setting: Department of Obstetrics and Gynecology, 1st Faculty of Medicine and General Teaching Hospital, Charles University in Prague.

Methods: Research of literature and current studies.

Conclusion: Based on the combination of personal medical history, clinical signs, biomarkers and transvaginal ultrasonographic measurement of cervical length, it is possible to predict preterm labour. To avoid a major prediction miscalculation, it is necessary to understand and correctly evaluate certain clinical findings. This approach decreases redundant medical intervention and therefore leads to amelioration of perinatal outcome.

Keywords:

cervicometry – Preterm birth – cervical length measurement – prediction

Zdroje

1. Abbot, DS., Hezelgrave, NL., Seed, PT. Quantitative fetal fibronectin to predict preterm birth in asymptomatic women at high risk. Obstet Gynecol, 2015, 125, p. 1168–1176.

2. Arisoy, R., Yayla, M. Transvaginal sonographic evaluation of the cervix in asymptomatic singleton pregnancy and management options in short cervix. J Pregnancy, 2012, Article ID 201628, https://doi.org/10.1155/2012/201628.

3. Berghella, V., Saccone, G. Fetal fibronectin testing for prevention of preterm birth in singleton pregnancies with threatened preterm labor: a systematic review and metaanalysis of randomized controlled trials. Am J Obstet Gynecol, 2016, 215, p. 431.

4. Bruijn, MM., Vis., JY, Wilms, FF., et al. Comparison of the Actim Partus test and the fetal fibronectin test in the prediction of spontaneous preterm birth in symptomatic women undergoing cervical length measurement. Eur J Obstet Gynecol Reprod Biol, 2016, 206, p. 220–224.

5. Calda, P., Břešťák, M., Fischerová, D., et al. Ultrazvuková diagnostika v těhotenství a gynekologii. Praha: Aprofema, 2010, 126 s.

6. Cavoretto, P, Candiani, M., Giorgione, V., et al. Risk of spontaneous preterm birth in singleton pregnancies conceived after IVF/ICSI treatment: meta-analysis of cohort studies. Ultrasound Obstet Gynecol, 2018, 51, p. 43–53.

7. Davey, MA., Watson, L., Rayner, JA., Rowland, S. Risk-scoring systems for predicting preterm birth with the aim of reducing associated adverse outcomes. Cochrane Datanase of Systematic Reviews, 2015, 10.

8. Edlow, AG., Srinivas, SK., Elovitz, MA. Second-trimester loss and subsequent pregnancy outcomes: What is the real risk? Am J Obstet Gynecol, 2007, 197, p. 581.

9. Einerson, BD., Grobman, WA., Miller, ES. Cost-effectiveness of risk-based screening for cervical length to prevent preterm birth. Am J Obstet Gynecol, 2016, 215, 1, p. 100e1–100e7.

10. Embleton, ND., Katz, J., Ziegler, EE. Low-birthweight baby: Born too soon or too small. Indian J Med Res, 2017, 145, p. 703–704.

11. https://fetalmedicine.org/education/cervical-assessment

12. Huang, H., Coleman, S., Bridge, JA., et al. A meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weight. Gen Hosp Psychiatry, 2014, 36, p. 13–15.

13. Kučera, R., Topolčan, O., Fiala, O. Účinky signální dráhy IGF1 (Insulin like Growth faktor 1) na vznik a rozvoj nádorových onemocnění. Klin Biochem Metab, 2016, 24, 1, s. 20–26.

14. Kyrgiou, M., Athanasiou, A., Kalliala, IEJ., et al. Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease. Cochrane Database Syst Rev. 2017, 11.

15. Lee, SE., Park, JS., Norwitz, ER., et al. Measurement of Placental-Alpha Microglobulin-1 in cervicovaginal discharge to diagnose rupture of membranes. Obstet Gynecol, 2007, 109, 3, p. 634–640.

16. Magro-Malloso, E., Seravalli, V., Cozzolino, M., et al. Prediction of preterm delivery by fetal fibronectin in symptomatic and asymptomatic women with cervical length ≤ 20 mm. J Matern Fetal Neonatal Med, 2017, 30, p. 294–297.

17. Maher, MA., Abdelaziz, A., Ellaithy, M., et al. Prevention of preterm birth: a randomized trial of vaginal compared with intramuscular progesterone. Acta Obstet Gynecol Scand, 2013, 92, p. 215–224.

18. McLaren, JS., Hezelgrave, NL., Ayubi, H., et al. Prediction of spontaneous preterm birth using quantitative fetal fibronectin after recent sexual intercourse. Am J Obstet Gynecol, 2015, 212, p. 89.

19. Mittal, P., Romero, R., Soto, E., et al. A role for placental alpha-microglobulin-1 in the identification of women with a sonographic short cervix at risk for spontaneous rupture of membranes. Am J Obstet Gynecol, 2009, 201, 6, p. 196–197.

20. Pařízek, A., Měchurová, A., Kacerovský, M., et. al. Spontánní předčasný porod. Doporučený postup. Čes Gynek, 2017, 82(2), s. 160–165.

21. Phillips, C., Velji, Z., Hanly, C., et al. Risk of recurrent spontaneous preterm birth: a systematic review and meta-analysis. BMJ Open, 2017; doi:10.1136/bmjopen-2016-015402.

22. Romero, R., Conde-Agudelo, A., Fonseca, E., et al. Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data. Am J Obstet Gynecol, 2018, 218(2), p. 161–168.

23. Romero, R., Dey, SK., Fisher, SJ. Preterm labor: one syndrome, many causes. Science, 2014, 15, p. 760–765.

24. Romero, R., Nicolaides, KH., Conde-Agudelo, A., et al. Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study. Ultrasound Obstet Gynecol, 2016, 48, p. 308.

25. Saade, GR., Thom, EA., Grobman, WA., et al. Cervical funneling or intra-amniotic debris and preterm birth in nulliparous women with midtrimester cervical length less than 30 mm. Ultrasound Obstet Gynecol, 2018, 52(6), p. 757–762.

26. Savitz, DA, Murnane, P. Behavioral influences on preterm birth: a review. Epidemiology, 2010, 21(3), p. 291–299.

27. Singer, E., Pilpel, S., Bsat, F., et al. Accuracy of fetal fibronectin to predict preterm birth in twin gestations with symptoms of labor. Obstet Gynecol, 2007, 109, p. 1083.

28. Sotiriadis, A., Papatheodorou, S., Kavvadias, A., et al. Transvaginal cervical length measurement for prediction of preterm birth in women with threatened preterm labor: a meta-analysis. Ultrasound Obstet Gynecol, 2010, 35(1), p. 54–64.

29. Souka, AP., Papastefanou, I., Pilalis, A., et al. Implementation of universal screening for preterm delivery by mid-trimester cervical length measurement. Ultrasound Obstet Gynecol, 2018, 10.1002/uog.19050.

30. Vahanian, SA., Lavery, JA., Ananth, CV., Vintzileos, A. Placental implantation abnormalities and risk of preterm delivery: a systematic review and metaanalysis. Am J Obstet Gynecol, 2015, 213, p. 78.

31. Valentin, L., Bergelin, I. Intra-and interobserver reproducibility of ultrasound measurements of cervical length and width in the second and third trimesters of pregnancy. Ultrasound Obstet Gynecol, 2002, 20, p. 256–262.

32. Watson, HA., Carter, J., Seed, PT., et al. The QUiPP App: a safe alternative to a treat-all strategy for threatened preterm labor. Ultrasound Obstet Gynecol, 2017, 50, p. 342–346.

33. Weiner, C., Zhou, H., Cuckle, H., et al. Futurebirth-prediction of future preterm birth <33w and preeclampsia/eclampsia <34w by 16w using a novel test in asymptomatic women. AJOG, 2017, 216(1), p. 196.

34. Wing, DA., Haeri, S., Silber, AC., et al. Placental alpha microglobulin-1 compared with fetal fibronectin to predict preterm delivery in symptomatic women. Obstet Gynecol, 2017, 130, p. 1183.